Profil
Max Fehlmann is the founder of two companies.
The Consortium Québécois sur la Découverte du Médicament was founded in 2008, and NEOMED-LABS, Inc. was founded in 2015.
At the Consortium Québécois sur la Découverte du Médicament, he holds the title of Director from 2008 to present.
At NEOMED-LABS, Inc., he held the title of Director from 2015 to 2017.
Dr. Fehlmann's current job is President & Chief Executive Officer at the Cancer Research Society, which he started in 2017.
Dr. Fehlmann's former jobs include President & Chief Executive Officer at Chronogen, Inc. from 2004 to 2010, Director-Research & Development at Zambon Company SpA from 1996 to 2003, and Principal at Institut National de la Santé & de la Recherche Médicale.
He was also President & Scientific Director at Institut de recherches cliniques de Montréal and Director at Neomed Institute.
Dr. Fehlmann received a doctorate degree from Université Laval.
Postes actifs de Max Fehlmann
| Sociétés | Poste | Début |
|---|---|---|
Consortium Québécois sur la Découverte du Médicament
Consortium Québécois sur la Découverte du Médicament Miscellaneous Commercial ServicesCommercial Services Operates as a drug discovery company | Fondateur | 01/01/2008 |
Cancer Research Society
Cancer Research Society Miscellaneous Commercial ServicesCommercial Services Provides cancer research services for charity | Directeur Général | 16/01/2017 |
Anciens postes connus de Max Fehlmann
| Sociétés | Poste | Fin |
|---|---|---|
NEOMED-LABS, Inc.
NEOMED-LABS, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Fondateur | 01/01/2017 |
Chronogen, Inc.
Chronogen, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat age-dependent diseases | President | 23/04/2010 |
Zambon Company SpA
Zambon Company SpA Pharmaceuticals: MajorHealth Technology Operates as a holding company with interests in pharmaceuticals and chemicals | Directeur Technique/Scientifique/R&D | 01/01/2003 |
Institut de recherches cliniques de Montréal
Institut de recherches cliniques de Montréal Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing biological systems | President | - |
Neomed Institute
Neomed Institute Pharmaceuticals: OtherHealth Technology Operates as a non-profit organization for pharmaceutical companies | Directeur/Membre du Conseil | - |
Formation de Max Fehlmann
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Chronogen, Inc.
Chronogen, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat age-dependent diseases | Health Technology |
Université Laval
Université Laval Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Institut National de la Santé & de la Recherche Médicale
Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Research institute | Commercial Services |
Institut de recherches cliniques de Montréal
Institut de recherches cliniques de Montréal Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing biological systems | Commercial Services |
Zambon Company SpA
Zambon Company SpA Pharmaceuticals: MajorHealth Technology Operates as a holding company with interests in pharmaceuticals and chemicals | Health Technology |
Cancer Research Society
Cancer Research Society Miscellaneous Commercial ServicesCommercial Services Provides cancer research services for charity | Commercial Services |
Neomed Institute
Neomed Institute Pharmaceuticals: OtherHealth Technology Operates as a non-profit organization for pharmaceutical companies | Health Technology |
Consortium Québécois sur la Découverte du Médicament
Consortium Québécois sur la Découverte du Médicament Miscellaneous Commercial ServicesCommercial Services Operates as a drug discovery company | Commercial Services |
NEOMED-LABS, Inc.
NEOMED-LABS, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
















